Free Trial

Titan Medical (TMDIF) Competitors

Titan Medical logo
$0.35 +0.02 (+4.82%)
As of 08/7/2025

TMDIF vs. TLSI, PROF, PDEX, KRMD, ELMD, LNSR, RCEL, LAKE, LUNG, and BSGM

Should you be buying Titan Medical stock or one of its competitors? The main competitors of Titan Medical include TriSalus Life Sciences (TLSI), Profound Medical (PROF), Pro-Dex (PDEX), KORU Medical Systems (KRMD), Electromed (ELMD), LENSAR (LNSR), Avita Medical (RCEL), Lakeland Industries (LAKE), Pulmonx (LUNG), and Biosig Technologies (BSGM). These companies are all part of the "medical equipment" industry.

Titan Medical vs. Its Competitors

TriSalus Life Sciences (NASDAQ:TLSI) and Titan Medical (NASDAQ:TMDIF) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, earnings, institutional ownership, dividends, valuation, media sentiment, analyst recommendations and risk.

TriSalus Life Sciences presently has a consensus price target of $10.75, suggesting a potential upside of 172.15%. Given TriSalus Life Sciences' stronger consensus rating and higher probable upside, equities analysts plainly believe TriSalus Life Sciences is more favorable than Titan Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
TriSalus Life Sciences
0 Sell rating(s)
0 Hold rating(s)
6 Buy rating(s)
2 Strong Buy rating(s)
3.25
Titan Medical
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Titan Medical has a net margin of 0.00% compared to TriSalus Life Sciences' net margin of -84.67%. TriSalus Life Sciences' return on equity of 0.00% beat Titan Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
TriSalus Life Sciences-84.67% N/A -111.63%
Titan Medical N/A -82.31%-51.47%

In the previous week, TriSalus Life Sciences had 1 more articles in the media than Titan Medical. MarketBeat recorded 1 mentions for TriSalus Life Sciences and 0 mentions for Titan Medical. TriSalus Life Sciences' average media sentiment score of 0.00 equaled Titan Medical'saverage media sentiment score.

Company Overall Sentiment
TriSalus Life Sciences Neutral
Titan Medical Neutral

2.6% of TriSalus Life Sciences shares are held by institutional investors. Comparatively, 0.0% of Titan Medical shares are held by institutional investors. 27.5% of TriSalus Life Sciences shares are held by insiders. Comparatively, 0.0% of Titan Medical shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Titan Medical has lower revenue, but higher earnings than TriSalus Life Sciences. TriSalus Life Sciences is trading at a lower price-to-earnings ratio than Titan Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
TriSalus Life Sciences$29.43M5.08-$30.05M-$1.12-3.53
Titan Medical$17.63M2.26$6.95M$0.057.00

TriSalus Life Sciences has a beta of 0.48, meaning that its stock price is 52% less volatile than the S&P 500. Comparatively, Titan Medical has a beta of 1.26, meaning that its stock price is 26% more volatile than the S&P 500.

Summary

TriSalus Life Sciences beats Titan Medical on 10 of the 16 factors compared between the two stocks.

Get Titan Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for TMDIF and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TMDIF and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TMDIF vs. The Competition

MetricTitan MedicalSurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$39.91M$72.88M$5.44B$9.61B
Dividend YieldN/AN/A4.61%4.14%
P/E Ratio-0.289.5029.7524.84
Price / Sales2.26108.10449.1298.65
Price / Cash0.0218.4136.4258.36
Price / Book0.336.808.185.64
Net Income$6.95M-$25.86M$3.26B$265.68M
7 Day Performance7.66%6.43%6.88%4.95%
1 Month Performance13.13%3.94%1.00%0.83%
1 Year PerformanceN/A48.20%28.85%22.18%

Titan Medical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TMDIF
Titan Medical
N/A$0.35
+4.8%
N/A+880.4%$39.91M$17.63M-0.2850
TLSI
TriSalus Life Sciences
2.0156 of 5 stars
$4.40
+1.5%
$10.75
+144.2%
-30.8%$166.61M$32.14M-3.93106Upcoming Earnings
PROF
Profound Medical
1.8014 of 5 stars
$5.54
+1.4%
$11.00
+98.7%
-42.4%$166.36M$10.68M-4.54150News Coverage
PDEX
Pro-Dex
1.9361 of 5 stars
$49.70
-3.5%
$56.00
+12.7%
+143.1%$162.22M$53.84M17.77140
KRMD
KORU Medical Systems
1.9026 of 5 stars
$3.47
-0.4%
$4.63
+33.5%
+59.7%$159.88M$33.65M-31.5080News Coverage
Earnings Report
ELMD
Electromed
2.1512 of 5 stars
$18.59
-1.2%
$33.50
+80.2%
+24.7%$155.64M$61.44M24.75160Positive News
LNSR
LENSAR
0.6448 of 5 stars
$13.18
+0.6%
$15.00
+13.8%
+222.6%$155.27M$53.49M-2.72110News Coverage
Positive News
Earnings Report
Upcoming Earnings
RCEL
Avita Medical
1.0484 of 5 stars
$5.28
-8.2%
$16.50
+212.5%
-46.4%$139.55M$64.25M-2.41130News Coverage
Earnings Report
Analyst Forecast
Gap Down
LAKE
Lakeland Industries
4.6913 of 5 stars
$13.98
-3.3%
$26.00
+86.0%
-38.3%$133.64M$177.65M-4.672,100Dividend Announcement
LUNG
Pulmonx
3.8164 of 5 stars
$3.13
+1.2%
$11.53
+268.6%
-73.6%$126.42M$83.79M-2.18250Positive News
Gap Up
BSGM
Biosig Technologies
2.1743 of 5 stars
$4.54
+2.3%
$10.00
+120.3%
+831.0%$123.83M$40K0.0050Upcoming Earnings

Related Companies and Tools


This page (NASDAQ:TMDIF) was last updated on 8/9/2025 by MarketBeat.com Staff
From Our Partners